Virus Infection, RNA Recruiting Phase 2 Trials for Tocilizumab (DB06273)

Also known as: RNA Virus Infections

IndicationStatusPhase
DBCOND0138959 (Virus Infection, RNA)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04476979Comparison of Tocilizumab Plus Dexamethasone vs. Dexamethasone for Patients With Covid-19Treatment